Friday December 15th 2017

Immune Modulation during Natalizumab Treatment of Multiple Sclerosis. (P2.252)

Conclusions: Natalizumab treatment induces complex modulation of both cellular and humoral immunity. The nadir of Candida albicans cellular responses (which might parallel JCV responses) coincides with the maximal period of PML risk and this test and flow cytometry could be integrated into a risk management program.Disclosure: Dr. Greenstein has received personal compensation for activities with SG Cowen as a consultant. (Source: Neurology)

Continued:  

Immune Modulation during Natalizumab Treatment of Multiple Sclerosis. (P2.252)

Leave a Comment

More from category

Germany’s Merck to make new bid to enter U.S. MS pill market
Germany’s Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the [Read More]

Researchers develop new method for quickly detecting signs of multiple sclerosis
Researchers develop new method for quickly detecting signs of multiple sclerosis

A METHOD for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research [Read More]

Terror survivors have increased risk of frequent migraine, tension headaches
Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, [Read More]

Scientists discover blood sample detection method for multiple sclerosis
Scientists discover blood sample detection method for multiple sclerosis

(University of Huddersfield) Researchers identified two natural biomarker compounds present in the blood. (Source: [Read More]

Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s
Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s

(Natural News) Parkinson’s disease is the second most common neurodegenerative disease plaguing people today, with an [Read More]